SCHEMBL30980581

SCHEMBL30980581

CC(=O)N[C@@H]1[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H](COCc2ccccc2)O[C@@H]1C#CCOCCOCCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.43
▸ MDM2 Q00987 2/20 0.43
▸ MDM4 O15151 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ BCHE P06276 1/20 0.39
▸ TACR2 P21452 3/20 0.36
▸ PTPN1 P18031 4/20 0.36
▸ CDC25B P30305 3/20 0.36
▸ NT5E P21589 1/20 0.36
▸ SSTR4 P31391 1/20 0.34
▸ TACR1 P25103 1/20 0.34
▸ PTPN2 P17706 1/20 0.34
▸ PTPN6 P29350 1/20 0.34
▸ CDC25A P30304 1/20 0.34
▸ PTPN11 Q06124 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980639 0.83 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980525 0.81 NT5E (0.41) BCHETACR2PTPN1CDC25BNT5E
SCHEMBL30980686 0.81 NT5E (0.41) BCHETACR2PTPN1CDC25BNT5E
SCHEMBL31078995 0.80 LMNA (0.43) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL31734181 0.79 TP53 (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980528 0.78 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980533 0.78 TP53 (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980622 0.77 TP53 (0.47) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980746 0.74 TP53 (0.44) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL24378386 0.74 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4651901-A1 CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback